Expert faculty members summarize key viral hepatitis studies from this important annual conference. Use these slides to review data on newer HCV regimens, the HCV continuum of care, posttreatment HCV outcomes, HCV D+R- transplantation, NA cessation in chronic hepatitis B, and investigational HBV/HDV therapeutics.
Listen to downloadable audio from a live Webinar by Jordan J. Feld, MD, MPH, in which the clinical impact of new viral hepatitis data reported at the San Francisco meeting is discussed.
Here’s my take on how data presented in San Francisco shed light on where we can improve HBV care.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.